DXtrade Adoption Report: 65% of Top Firms Now Offer DXtrade
Our quarterly platform adoption survey reveals a landmark shift: DXtrade is now offered by 65% of top-tier prop trading firms, surpassing MetaTrader 5 (58%) for the first time ever.
Platform Market Share (Q1 2026)
| Platform | Adoption Rate | Change from Q4 2025 |
|----------|--------------|---------------------|
| DXtrade | 65% | +12% |
| MT5 | 58% | -8% |
| MatchTrader | 42% | +15% |
| cTrader | 28% | +3% |
| TradeLocker | 15% | +6% |
| MT4 | 12% | -10% |
Key Observations
1. DXtrade wins on compliance: The primary driver isn't feature superiority — it's regulatory safety. DXtrade doesn't carry MetaQuotes licensing risk.
2. MatchTrader is the fastest grower: With a 15% increase in adoption quarter-over-quarter, MatchTrader is aggressively capturing firms transitioning away from MetaTrader.
3. MT4 is dying: Down to just 12% adoption, MT4 is effectively legacy-only. No new prop firm is launching with MT4 as a primary platform.
4. Multi-platform is the norm: 78% of top firms now offer 2+ platform options, up from 45% a year ago. This gives traders unprecedented choice.
What This Means for Traders
If you've been exclusively trading on MetaTrader, now is the time to explore DXtrade and MatchTrader. Both offer web-based interfaces that don't require downloads, and both have made significant UX improvements in recent months. The learning curve is minimal for anyone comfortable with MT5's interface.
Related News
Earn2Trade Launches Direct Tradovate Integration
Futures traders can now connect Earn2Trade evaluations directly with Tradovate, bypassing traditional data feed software.
MetaQuotes Compliance Wave Forces 12+ Firms to Drop MT4/MT5
A new round of MetaQuotes license enforcement has forced over a dozen prop firms to migrate away from MetaTrader platforms, accelerating the industry shift toward DXtrade and MatchTrader.
The Rise of Prop Firm 'Insurance': Should You Buy Payout Protection?
A growing trend sees third-party services offering 'payout insurance' for prop firm traders. We analyze whether these products are worth the cost.